Scale matters: the need for a Bipolar Depression Rating Scale (BDRS)

IF 5.3 2区医学 Q1 PSYCHIATRY Acta Psychiatrica Scandinavica Pub Date : 2004-08-27 DOI:10.1111/j.1600-0447.2004.00412.x

M. Berk, G. S. Malhi, P. B. Mitchell, C. M. Cahill, A. C. Carman, D. Hadzi-Pavlovic, M. T. Hawkins, M. Tohen

{"title":"Scale matters: the need for a Bipolar Depression Rating Scale (BDRS)","authors":"M. Berk, G. S. Malhi, P. B. Mitchell, C. M. Cahill, A. C. Carman, D. Hadzi-Pavlovic, M. T. Hawkins, M. Tohen","doi":"10.1111/j.1600-0447.2004.00412.x","DOIUrl":null,"url":null,"abstract":"Objective: To briefly review the clinical and biological distinctions between unipolar and bipolar depression critiquing in particular currently available depression rating scales and discuss the need for a new observer-rated scale tailored to bipolar depression.Method: Relevant literature pertaining to the symptomatic differences between bipolar disorder and unipolar disorder as well as their measurement using existing assessment scales was identified by computerized searches and reviews of scientific journals known to the authors.Results: Bipolar depression is distinct from unipolar depression in terms of phenomenology and clinical characteristics. These distinguishing features can be used to identify bipolarity in patients that present with recurrent depressive episodes. This is important because current self-report and observer-rated scales are optimized for unipolar depression, and hence limited in their ability to accurately assess bipolar depression.Conclusion: The development of a specific bipolar depression rating scale will improve the assessment of bipolar depression in both research and clinical settings and assist the development of better treatments and interventions.","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"110 s422","pages":"39-45"},"PeriodicalIF":5.3000,"publicationDate":"2004-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1600-0447.2004.00412.x","citationCount":"61","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Psychiatrica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.2004.00412.x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 61

Abstract

Objective: To briefly review the clinical and biological distinctions between unipolar and bipolar depression critiquing in particular currently available depression rating scales and discuss the need for a new observer-rated scale tailored to bipolar depression.

Method: Relevant literature pertaining to the symptomatic differences between bipolar disorder and unipolar disorder as well as their measurement using existing assessment scales was identified by computerized searches and reviews of scientific journals known to the authors.

Results: Bipolar depression is distinct from unipolar depression in terms of phenomenology and clinical characteristics. These distinguishing features can be used to identify bipolarity in patients that present with recurrent depressive episodes. This is important because current self-report and observer-rated scales are optimized for unipolar depression, and hence limited in their ability to accurately assess bipolar depression.

Conclusion: The development of a specific bipolar depression rating scale will improve the assessment of bipolar depression in both research and clinical settings and assist the development of better treatments and interventions.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

量表很重要:双相抑郁评定量表(BDRS)的必要性

目的:简要回顾单相抑郁症和双相抑郁症的临床和生物学区别，特别是目前可用的抑郁评定量表，并讨论针对双相抑郁症量身定制的新的观察者评定量表的必要性。方法:通过计算机检索和回顾作者所知的科学期刊，确定有关双相情感障碍和单相情感障碍症状差异的相关文献以及使用现有评估量表的测量方法。结果:双相抑郁症在症状和临床特征上与单极抑郁症不同。这些显著特征可用于识别复发性抑郁发作患者的双极性。这一点很重要，因为目前的自我报告和观察者评定量表是针对单相抑郁症进行优化的，因此它们在准确评估双相抑郁症方面的能力有限。结论:开发一种特定的双相抑郁评定量表将改善双相抑郁的研究和临床评估，并有助于开发更好的治疗和干预措施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Acta Psychiatrica Scandinavica 医学-精神病学

CiteScore

11.20

自引率

3.00%

发文量

135

审稿时长

6-12 weeks

期刊介绍： Acta Psychiatrica Scandinavica acts as an international forum for the dissemination of information advancing the science and practice of psychiatry. In particular we focus on communicating frontline research to clinical psychiatrists and psychiatric researchers. Acta Psychiatrica Scandinavica has traditionally been and remains a journal focusing predominantly on clinical psychiatry, but translational psychiatry is a topic of growing importance to our readers. Therefore, the journal welcomes submission of manuscripts based on both clinical- and more translational (e.g. preclinical and epidemiological) research. When preparing manuscripts based on translational studies for submission to Acta Psychiatrica Scandinavica, the authors should place emphasis on the clinical significance of the research question and the findings. Manuscripts based solely on preclinical research (e.g. animal models) are normally not considered for publication in the Journal.